Global PGx Services RPRD Diagnostics serves healthcare providers and pharmaceutical companies worldwide with precision medicine pharmacogenomics testing and analysis, presenting opportunities to expand enterprise-level collaborations, managed services, and large-scale integration with clinical decision support systems.

Pediatric Focus As the PGx reference lab for leading pediatric cancer centers, there is a strong opening to upsell specialized panels such as the CNT Panel for leukemia drug toxicity risk, and to pursue multi-site pediatric oncology partnerships and reimbursement-ready testing programs.

Cost and Outcomes Tests are positioned to support clinical decision-making, improve patient outcomes, and reduce costs, providing a compelling value proposition for health systems and payers seeking outcomes-driven pharmacogenomics solutions.

Strategic Partnerships Past collaboration with Children’s Minnesota indicates readiness for joint programs with pediatric centers, enabling co-development of pharmacogenomic workflows, data sharing, and implementation at scale.

Digital and Cloud Enablement Current tech stack including Google Cloud, Salesforce, and marketing platforms suggests capacity for scalable data management, CRM-driven outreach, and partner enablement; opportunities exist to offer integrated analytics, dashboards, and provider onboarding tools.